GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Change In Inventory : ₦2,306 Mil (TTM As of Jun. 2023)

View and export this data going back to 2001. Start your Free Trial

What is GlaxoSmithKline Consumer Nigeria Change In Inventory?

GlaxoSmithKline Consumer Nigeria's change in inventory for the quarter that ended in Jun. 2023 was ₦0 Mil. It means GlaxoSmithKline Consumer Nigeria's inventory stayed the same from Dec. 2022 to Jun. 2023 .

GlaxoSmithKline Consumer Nigeria's change in inventory for the fiscal year that ended in Dec. 2022 was ₦2,306 Mil. It means GlaxoSmithKline Consumer Nigeria's inventory declined by ₦2,306 Mil from Dec. 2021 to Dec. 2022 .

GlaxoSmithKline Consumer Nigeria's Total Inventories for the quarter that ended in Jun. 2023 was ₦2,182 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. GlaxoSmithKline Consumer Nigeria's Days Inventory for the quarter that ended in Jun. 2023 was 111.76.

Inventory Turnover measures how fast the company turns over its inventory within a year. GlaxoSmithKline Consumer Nigeria's Inventory Turnover for the quarter that ended in Jun. 2023 was 0.82.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. GlaxoSmithKline Consumer Nigeria's Inventory-to-Revenue for the quarter that ended in Jun. 2023 was 0.79.

GlaxoSmithKline Consumer Nigeria Change In Inventory Historical Data

The historical data trend for GlaxoSmithKline Consumer Nigeria's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GlaxoSmithKline Consumer Nigeria Change In Inventory Chart

GlaxoSmithKline Consumer Nigeria Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Change In Inventory

Get a 7-Day Free Trial

-570.28

-1,555.47

2,242.48

-2,762.96

2,305.86

GlaxoSmithKline Consumer Nigeria Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23
Change In Inventory	Get a 7-Day Free Trial															-1,215.01	2,054.79	1,357.41	108.66	-

GlaxoSmithKline Consumer Nigeria Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₦2,306 Mil.

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

GlaxoSmithKline Consumer Nigeria's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	2960.8915	/	2417.612	*	365 / 4
	=	111.76

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

GlaxoSmithKline Consumer Nigeria's Inventory Turnover for the quarter that ended in Jun. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	2417.612	/	2960.8915
	=	0.82

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

GlaxoSmithKline Consumer Nigeria's Inventory to Revenue for the quarter that ended in Jun. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	2960.8915	/	3731.801
	=	0.79

GlaxoSmithKline Consumer Nigeria Change In Inventory Related Terms

Thank you for viewing the detailed overview of GlaxoSmithKline Consumer Nigeria's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GlaxoSmithKline Consumer Nigeria PLC (NSA:GLAXOSMITH) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1, Industrial Avenue, Ilupeju, P.M.B. 21218, Ikeja, GSK House, Lagos, NGA

Website

https://www.ng.gsk.com

GlaxoSmithKline Consumer Nigeria PLC is a healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products. The company has two reportable segments, the Consumer Healthcare segment consisting of oral care, over-the-counter (OTC) medicines, and nutritional healthcare; and the Pharmaceuticals segment consisting of vaccines and prescription drugs. The company's product line includes panadol, Andrews liver salt, Macleans, ampiclox, Sensodyne, and others. The generates maximum revenue from the Pharmaceuticals segment.

GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Headlines

No Headlines